Antisense Pharma Receives FDA Orphan Drug Designation for Trabedersen to Treat Malignant Melanoma

TGF-β2 inhibitor has gained market exclusivity in the USA for a third aggressive cancer indication

25-Jul-2012 - Germany

Other news from the department research and development

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance